Targeting the WNT/Β-Catenin Pathway in Primary Ovarian Cancer With the Porcupine Inhibitor WNT974
Laboratory Investigation - United Kingdom
doi 10.1038/labinvest.2015.150
Full Text
Open PDFAbstract
Available in full text
Date
December 14, 2015
Authors
Publisher
Springer Science and Business Media LLC